Synthesis and resolution of 2-(cyclohexyl-4-(2-quinolylmethoxy)phenyl)methoxyiminopropionic acid, leukotriene biosynthesis inhibitors
摘要:
The synthesis and resolution of 2-(E)-(cyclohexyl-4-(2-quinolylmethoxy)phenyl)methoxyiminopropionic acid 1, a potent leukotriene biosynthesis inhibitor is described. Dibenzoyltartaric acid was used as the chiral auxiliary for the resolution of the hydroxylamine intermediates used in the synthesis. A difficult chromatographic separation was made more practical by changing the order of elution of diastereomers by selection of the natural or unatural tartaric acid auxiliary. Copyright (C) 1996 Elsevier Science Ltd
Synthesis and resolution of 2-(cyclohexyl-4-(2-quinolylmethoxy)phenyl)methoxyiminopropionic acid, leukotriene biosynthesis inhibitors
摘要:
The synthesis and resolution of 2-(E)-(cyclohexyl-4-(2-quinolylmethoxy)phenyl)methoxyiminopropionic acid 1, a potent leukotriene biosynthesis inhibitor is described. Dibenzoyltartaric acid was used as the chiral auxiliary for the resolution of the hydroxylamine intermediates used in the synthesis. A difficult chromatographic separation was made more practical by changing the order of elution of diastereomers by selection of the natural or unatural tartaric acid auxiliary. Copyright (C) 1996 Elsevier Science Ltd
Synthesis and resolution of 2-(cyclohexyl-4-(2-quinolylmethoxy)phenyl)methoxyiminopropionic acid, leukotriene biosynthesis inhibitors
作者:Teodozyj Kolasa、David E. Gunn、Andrew O. Stewart、Clint D.W. Brooks
DOI:10.1016/0957-4166(96)00340-0
日期:1996.9
The synthesis and resolution of 2-(E)-(cyclohexyl-4-(2-quinolylmethoxy)phenyl)methoxyiminopropionic acid 1, a potent leukotriene biosynthesis inhibitor is described. Dibenzoyltartaric acid was used as the chiral auxiliary for the resolution of the hydroxylamine intermediates used in the synthesis. A difficult chromatographic separation was made more practical by changing the order of elution of diastereomers by selection of the natural or unatural tartaric acid auxiliary. Copyright (C) 1996 Elsevier Science Ltd